Suven Life Sciences Faces Bearish Technical Trends Amid Market Evaluation Revision
Suven Life Sciences, a small-cap pharmaceutical company, has seen its stock price decline recently, with notable fluctuations compared to the Sensex. Technical indicators suggest a bearish sentiment, and while the stock has struggled year-to-date, it has shown positive returns over a three-year period.
Suven Life Sciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 103.10, down from a previous close of 108.00, with a 52-week high of 169.00 and a low of 83.27. Today's trading saw a high of 107.95 and a low of 102.70.The technical summary indicates a bearish sentiment across various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective is mildly bearish. Bollinger Bands also reflect a bearish stance for both weekly and monthly evaluations. Moving averages are bearish on a daily basis, and the KST presents a mixed picture with a bearish weekly trend and a bullish monthly outlook.
In terms of performance, Suven Life Sciences has experienced notable fluctuations compared to the Sensex. Over the past week, the stock returned -11.99%, while the Sensex saw a decline of only -2.81%. Year-to-date, the stock has returned -19.86%, contrasting with the Sensex's -6.32%. However, over a longer horizon, such as three years, Suven has shown a return of 29.93%, slightly trailing the Sensex's 30.14%. This evaluation adjustment highlights the company's current challenges in the market while also reflecting its historical performance trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
